Valuation: Divi's Laboratories Limited

Market Cap 2,28000Cr 2.38TCr 2.06TCr 1.93TCr 1.76TCr 3.31TCr 3.35TCr 23TCr 8.89TCr 1,14000Cr 8.93TCr 8.74TCr 3,79800Cr P/E 2027 *
70.1x
P/E 2028 * 58.1x
Enterprise Value 2,24500Cr 2.34TCr 2.02TCr 1.9TCr 1.73TCr 3.25TCr 3.3TCr 22TCr 8.75TCr 1,12300Cr 8.8TCr 8.61TCr 3,74000Cr EV / Sales 2027 *
17.9x
EV / Sales 2028 * 14.9x
Free-Float
48.01%
Yield 2027 *
0.41%
Yield 2028 * 0.45%
1 day-0.33%
1 week-0.47%
Current month+6.26%
1 month+16.97%
3 months+23.84%
6 months+35.93%
Current year+33.91%
1 week 8,414
Extreme 8414
8,630
1 month 7,177
Extreme 7177
8,674
Current year 5,647.5
Extreme 5647.5
8,674
1 year 5,636.5
Extreme 5636.5
8,674
3 years 3,295.3
Extreme 3295.3
8,674
5 years 2,730
Extreme 2730
8,674
10 years 532.65
Extreme 532.65
8,674
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%-0.47%+40.80%+133.54% 2.38TCr
+4.48%+3.15%+79.00%+128.84% 1,09300Cr
+1.54%+4.02%+52.62%+62.15% 65TCr
+2.26%+4.70%+26.32%+73.45% 46TCr
+1.52%-0.36%+39.97%+43.22% 35TCr
+1.33%+1.21%+24.58%+39.67% 29TCr
+2.32%+1.86%+1.17%+11.67% 25TCr
+3.27%+3.25%+45.40%+64.84% 23TCr
+1.55%-0.67%-14.52%-52.82% 20TCr
+3.24%+6.82%+23.02%+91.12% 18TCr
Average +1.98%+1.09%+31.83%+59.57% 37.34TCr
Weighted average by Cap. +2.59%+1.45%+44.71%+71.88%

Financials

2027 *2028 *
Net sales 13TCr 131.15Cr 113.28Cr 106.58Cr 97Cr 182.19Cr 184.86Cr 1.25TCr 489.95Cr 6.28TCr 492.42Cr 481.73Cr 21TCr 15TCr 156.44Cr 135.11Cr 127.13Cr 115.54Cr 217.31Cr 220.5Cr 1.49TCr 584.4Cr 7.5TCr 587.34Cr 574.59Cr 25TCr
Net income 3.26TCr 34Cr 29Cr 28Cr 25Cr 47Cr 48Cr 324.02Cr 126.98Cr 1.63TCr 127.62Cr 124.85Cr 5.43TCr 3.94TCr 41Cr 35Cr 33Cr 30Cr 57Cr 58Cr 391.64Cr 153.48Cr 1.97TCr 154.26Cr 150.91Cr 6.56TCr
Net Debt -3.5TCr -37Cr -32Cr -30Cr -27Cr -51Cr -51Cr -348.2Cr -136.46Cr -1.75TCr -137.15Cr -134.17Cr -5.83TCr -4.49TCr -47Cr -40Cr -38Cr -35Cr -65Cr -66Cr -446.24Cr -174.88Cr -2.24TCr -175.76Cr -171.95Cr -7.47TCr
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
19/26/19 8,560.00 -0.33% 1,79,152
18/26/18 ₹8,588.00 +1.26% 4,04,163
17/26/17 ₹8,481.50 +0.05% 2,52,029
14/26/14 ₹8,477.00 -0.27% 3,40,336
13/26/13 ₹8,500.00 -1.16% 3,44,131
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
8,588.00INR
Average target price
8,292.48INR
Spread / Average Target
-3.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock